Presentation is loading. Please wait.

Presentation is loading. Please wait.

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Published byIrwan Halim Modified over 5 years ago

Similar presentations

Presentation on theme: "Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,"— Presentation transcript:

1 Surgical treatment of hepatic and pulmonary metastases from colon cancer 
James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen, MD, Claude Deschamps, MD, Victor F Trastek, MD, Peter C Pairolero, MD  The Annals of Thoracic Surgery  Volume 71, Issue 3, Pages (March 2001) DOI: /S (00)

2 Fig 1 Probability of survival (death from any cause) in 58 patients who underwent resection of hepatic and pulmonary metastasis from colon cancer. Zero time on abscissa represents date of first lung resection. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

3 Fig 2 Probability of survival (death from any cause) in 11 patients with normal preoperative carcinoembryonic antigen (CEA) levels as compared to 16 patients with abnormal (> 5 ng/mL) carcinoembryonic antigen levels. Zero time on abscissa represents date of first lung resection. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

4 Fig 3 Probability of survival (death from any cause) in 13 patients who had adjuvant therapy after pulmonary resection as compared to 45 patients who had none. Zero time on abscissa represents date of first lung resection. (Tx = therapy). The Annals of Thoracic Surgery  , DOI: ( /S (00) )

5 Fig 4 Probability of survival (death from any cause) in 16 patients who underwent additional lung resections for recurrent disease. Zero time on abscissa represents date of second lung resection. The Annals of Thoracic Surgery  , DOI: ( /S (00) )

Download ppt "Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,"

Similar presentations

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,

Surgical treatment of hepatic and pulmonary metastases from colon cancer  James R Headrick, MD, Daniel L Miller, MD, David M Nagorney, MD, Mark S Allen,
Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment  William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.
The STS National Database

The STS National Database
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy  James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,

High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy  James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,
Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients  Joachim Pfannschmidt,

Prognostic factors and survival after complete resection of pulmonary metastases from colorectal carcinoma: Experiences in 167 patients  Joachim Pfannschmidt,
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma  Sina Ercan, MD, Francis C Nichols,

Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma  Sina Ercan, MD, Francis C Nichols,
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Similar presentations

Ads by Google